Skip to main content

Table 1 Clinical and biological characteristics of patients

From: Mineral bone disorder and osteoporosis in hemodialysis patients

Age, mean ± SD yesars53.01 ± 14.66
Height, mean ± SD cm162.78 ± 9.77
Weight, mean ± SD Kg68.33 ± 13.48
Body mass index, mean ± SD kg/m225.79 ± 4.67
Smoking (n (%))50 (55.5)
Adequate exposure to sunlight (n (%))55 (61)
ComorbiditiesDiabetes (n (%))38 (42)
Hypertension (n (%))60 (66)
Dyslipidemia12 (13)
Duration of dialysis, mean ± SD years3.94 ± 1.99
Causes of CKDDiabetic nephropathy (n (%))30 (33.3)
Vascular nephropathy (n (%))6 (6.6)
Glomerulonephritis (n (%))40 (44.5)
Amyloidosis (n (%))1 (1.2)
Polycystic kidney disease (n (%))4 (4.4)
Tubulointerstitial nephropathy (n (%))9 (10)
Calcium (2–2.25 mmo/L)2.08 ± 0.32
Phosphate (2–2.25 mmo/L)1.84 ± 0.57
Albumin (30-45 mmom/L)35.45 ± 5.64
Total alkaline phosphatase (60–220 U/L)88.35 ± 72.56
PTH (12-65 pgmL)425.7 ± 380.8
25 OH-vitamin D (ng/L)15.76 ± 11.58
bAP (ng/mL)26.84 ± 26.99
CTX (ng/mL)2.49 ± 1.51
FGF 23 (pg/mL)221.87 ± 248.96
  1. Data are presented as mean ± standard deviation, CKD Chronic kidney disease, PTH Parathyroid hormone, bAP bone alkaline phosphatase, CTX C-terminal telopeptide of type I collagen, FGF 23 Fibroblast growth factor 23